Anti-ANGL6/ ANGPTL6/ AGF functional antibody

Anti-ANGL6/ ANGPTL6/ AGF functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ANGPTL6/ANGPTL6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0668-Ab-1/ GM-Tg-hg-SE0668-Ab-2Anti-Human ANGPTL6 monoclonal antibodyHuman
GM-Tg-rg-SE0668-Ab-1/ GM-Tg-rg-SE0668-Ab-2Anti-Rat ANGPTL6 monoclonal antibodyRat
GM-Tg-mg-SE0668-Ab-1/ GM-Tg-mg-SE0668-Ab-2Anti-Mouse ANGPTL6 monoclonal antibodyMouse
GM-Tg-cynog-SE0668-Ab-1/ GM-Tg-cynog-SE0668-Ab-2Anti-Cynomolgus/ Rhesus macaque ANGPTL6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0668-Ab-1/ GM-Tg-felg-SE0668-Ab-2Anti-Feline ANGPTL6 monoclonal antibodyFeline
GM-Tg-cang-SE0668-Ab-1/ GM-Tg-cang-SE0668-Ab-2Anti-Canine ANGPTL6 monoclonal antibodyCanine
GM-Tg-bovg-SE0668-Ab-1/ GM-Tg-bovg-SE0668-Ab-2Anti-Bovine ANGPTL6 monoclonal antibodyBovine
GM-Tg-equg-SE0668-Ab-1/ GM-Tg-equg-SE0668-Ab-2Anti-Equine ANGPTL6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0668-Ab-1/ GM-Tg-hg-SE0668-Ab-2; GM-Tg-rg-SE0668-Ab-1/ GM-Tg-rg-SE0668-Ab-2;
GM-Tg-mg-SE0668-Ab-1/ GM-Tg-mg-SE0668-Ab-2; GM-Tg-cynog-SE0668-Ab-1/ GM-Tg-cynog-SE0668-Ab-2;
GM-Tg-felg-SE0668-Ab-1/ GM-Tg-felg-SE0668-Ab-2; GM-Tg-cang-SE0668-Ab-1/ GM-Tg-cang-SE0668-Ab-2;
GM-Tg-bovg-SE0668-Ab-1/ GM-Tg-bovg-SE0668-Ab-2; GM-Tg-equg-SE0668-Ab-1/ GM-Tg-equg-SE0668-Ab-2
Products NameAnti-ANGPTL6 monoclonal antibody
Formatmab
Target NameANGPTL6
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANGPTL6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0668-Ag-1Recombinant multi-species ANGL6/ ANGPTL6/ AGF protein
    ORF Viral VectorpGMLPm004493mouse Angptl6 Lentivirus plasmid
    ORF Viral VectorvGMLPm004493mouse Angptl6 Lentivirus particle


    Target information

    Target IDGM-SE0668
    Target NameANGPTL6
    Gene ID83854,70726,298698,106994633,611293,101088649,521472,100058425
    Gene Symbol and Synonyms6330404E11Rik,AGF,Angpt16,ANGPTL6,ARP3,ARP5
    Uniprot AccessionQ8NI99
    Uniprot Entry NameANGL6_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130812
    Target ClassificationN/A

    The target: ANGPTL6, gene name: ANGPTL6, also named as AGF, ARP5. Predicted to enable signaling receptor binding activity. Predicted to be involved in angiogenesis and cell differentiation. Located in extracellular exosome. Part of collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.